Kaleorid

Potassium Chloride, the active ingredient in Kaleorid, is an electrolyte presented as an oral formulation for oral use. It treats potassium deficiency and hypokalemia by restoring normal serum potassium levels in patients who require electrolyte replacement. It is indicated for patients with documented low potassium levels and is commonly used in acute care and chronic management settings.

GNH USA supplies Kaleorid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, sourcing the product from EU‑regulated manufacturers to ensure quality and compliance.

Kaleorid (potassium chloride) is used to correct electrolyte disturbances related to low potassium levels.

- Hypokalemia: restores serum potassium to the normal range, reducing muscle weakness and cardiac arrhythmias. - Potassium deficiency: provides essential potassium ions to maintain cellular function and nerve conduction. - Cardiac arrhythmia risk due to low potassium: helps stabilize cardiac electrical activity and prevent arrhythmic events.

Oral potassium chloride may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate feeling of stomach upset. - Abdominal cramping: discomfort or pain in the abdomen. - Diarrhea or constipation: altered bowel habits. - Taste disturbance: metallic or salty taste perception.

Serious or Rare Side Effects: - Severe hyperkalemia: dangerously high serum potassium that can affect heart rhythm. - Cardiac arrhythmia: irregular heartbeat potentially leading to syncope. - Allergic reaction: rash, itching, swelling, or anaphylaxis in rare cases.

When prescribing Kaleorid, clinicians should consider several safety measures.

- Monitor serum potassium: check levels before initiation and periodically during therapy. - Adjust dose in renal impairment: reduced kidney function can increase risk of hyperkalemia. - Avoid in existing hyperkalemia: contraindicated when serum potassium is already elevated. - Caution with ACE inhibitors or potassium‑sparing diuretics: these agents may potentiate potassium accumulation. - Use ECG monitoring in high‑risk patients: detect potential cardiac effects early. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Potassium chloride can interact with several medications, influencing potassium balance.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may cause additive hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of severe hyperkalemia. - Trimethoprim: can reduce renal potassium excretion.

Moderate Interactions (Monitor Closely): - Digoxin: elevated potassium can alter digoxin toxicity risk. - NSAIDs: may impair renal potassium handling. - Beta‑blockers: may mask symptoms of hyperkalemia. - Lithium: concurrent use may affect lithium clearance.